An FDA chairwoman of an advisory panel to the Food and Drug Administration canceled her scheduled participation at a conference in February after a consumer rights group Thursday leveled conflict of interest charges and sent a letter of complaint to FDA Commissioner Margaret Hamburg.
Dr. Lynn Drake, a lecturer at Harvard Medical School and current chairwoman of the panel that advises the FDA on drugs to treat skin and eye conditions, was scheduled to counsel drug companies at the conference on ways to improve their chances of winning favorable recommendations for their products.
The stated aim of the conference is to help companies “walk away with strategies to successfully present before a committee and avoid potential roadblocks.”
FDA advisory committees exist to give the agency an independent assessment of a company’s application to market a new drug.
Photo: Susan Biddle/The Washington Post/Getty Images